Cargando…

Prediction of Recurrent Venous Thromboembolism by Clot Lysis Time: A Prospective Cohort Study

Venous thromboembolism (VTE) is a chronic disease, which tends to recur. Whether an abnormal fibrinolytic system is associated with an increased risk of VTE is unclear. We assessed the relationship between fibrinolytic capacity (reflected by clot lysis time [CLT]) and risk of recurrent VTE. We follo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traby, Ludwig, Kollars, Marietta, Eischer, Lisbeth, Eichinger, Sabine, Kyrle, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519893/ https://www.ncbi.nlm.nih.gov/pubmed/23240024 http://dx.doi.org/10.1371/journal.pone.0051447

Ejemplares similares

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study
por: Eischer, Lisbeth, et al.
Publicado: (2012)

Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury
por: Eichinger, Sabine, et al.
Publicado: (2018)

Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects
por: Krammer, Teresa L., et al.
Publicado: (2022)

d‐Dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model
por: Eichinger, Sabine, et al.
Publicado: (2014)

Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers
por: Traby, Ludwig, et al.
Publicado: (2019)

Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy
por: Puhr, Hannah C., et al.
Publicado: (2022)

A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
por: Boudjeltia, K Zouaoui, et al.
Publicado: (2002)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
por: Ramberg, Cathrine, et al.
Publicado: (2021)

Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study
por: Nilius, Henning, et al.
Publicado: (2021)

Fibrin Clot Formation and Lysis in Plasma
por: Larsen, Julie Brogaard, et al.
Publicado: (2020)

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2019)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
por: Douketis, James, et al.
Publicado: (2011)

Impaired contraction of blood clots precedes and predicts postoperative venous thromboembolism
por: Evtugina, Natalia G., et al.
Publicado: (2020)

Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non‐recurrent disease
por: Baker, Stephen R., et al.
Publicado: (2019)

Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients—a prospective interventional study
por: Takai, Shigeki, et al.
Publicado: (2022)

Congruent identification of imbalanced fibrinolysis by 2 distinct clot lysis time assays
por: Driever, Ellen G., et al.
Publicado: (2023)

Statin therapy and recurrent venous thromboembolism in the elderly: a prospective cohort study
por: Kronenberg, Regula Monika, et al.
Publicado: (2019)

Properties of Plasma Clots in Adult Patients Following Fontan Procedure: Relation to Clot Permeability and Lysis Time—Multicenter Study
por: Skubera, Maciej, et al.
Publicado: (2021)

Plasma Clot Lysis Time and Its Association with Cardiovascular Risk Factors in Black Africans
por: de Lange, Zelda, et al.
Publicado: (2012)

Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Reduced fibrin clot lysis in Klinefelter syndrome associated with hypogonadism
por: Chang, Simon, et al.
Publicado: (2022)

Determination of Biological Activity of Recombinant Reteplase Using Clot Lysis Time and Activated Partial Thromboplastin Time (APTT) Lysis Methods: A Comparative Study
por: Babaee, Tahereh, et al.
Publicado: (2018)

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause
por: Hofer, Stefanie, et al.
Publicado: (2019)

Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2017)

Reduced Contraction of Blood Clots in Venous Thromboembolism Is a Potential Thrombogenic and Embologenic Mechanism
por: Peshkova, Alina D., et al.
Publicado: (2018)

THE LYSIS IN RABBITS OF INTRAVASCULAR BLOOD CLOTS BY THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM (STREPTOKINASE)
por: Johnson, Alan J., et al.
Publicado: (1952)

Development of an in vitro model to study clot lysis activity of thrombolytic drugs
por: Prasad, Sweta, et al.
Publicado: (2006)

Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts
por: Shivasharanappa, Kirankumar, et al.
Publicado: (2014)

The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
por: Bollen, Lize, et al.
Publicado: (2015)

Investigating the two regimes of fibrin clot lysis: an experimental and computational approach
por: Raynaud, Franck, et al.
Publicado: (2021)

Citrullinated Fibrinogen Renders Clots Mechanically Less Stable, but Lysis-Resistant
por: Varjú, Imre, et al.
Publicado: (2021)

Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2018)

Unfavourably altered plasma clot properties in patients with primary Raynaud’s phenomenon: association with venous thromboembolism
por: Żuk, Joanna, et al.
Publicado: (2019)

The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients
por: Cano, Stefan J, et al.
Publicado: (2012)

D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan　― From the CLOT-COVID Study ―
por: Ikeda, Nobutaka, et al.
Publicado: (2022)

P1641: RECURRENT VENOUS THROMBOEMBOLISMS AND ANTICOAGULATION COMPLICATIONS; A PROSPECTIVE STUDY.
por: Nasibov, Teymur, et al.
Publicado: (2023)

Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism
por: Tan, Chuen Wen, et al.
Publicado: (2019)

Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study
por: Mueller, Carolin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bj1vlh69s2crn4ljrlskssivtr